Extreme ecchymoses in a migraine patient using concomitant treatment with calcitonin gene-related peptide receptor antibodies and fish oil supplements: a case report

BACKGROUND: Erenumab, a monoclonal antibody against the calcitonin gene-related peptide (CGRP) receptor, is registered for migraine prevention. Compared to other conventional migraine prevention medicines (i.e. topiramate, betablockers and amitriptyline) erenumab has better tolerability. Impaired he...

Descripción completa

Detalles Bibliográficos
Autores principales: Cullum, C. K., Olsen, M. K., Kocadag, H. B., Ashina, M., Amin, F. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252281/
https://www.ncbi.nlm.nih.gov/pubmed/34215196
http://dx.doi.org/10.1186/s12883-021-02294-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252281/
https://www.ncbi.nlm.nih.gov/pubmed/34215196
http://dx.doi.org/10.1186/s12883-021-02294-6

Ejemplares similares